// App-Quantinova.ai

2103-312 : TWO-YEAR CLINICAL OUTCOMES OF THE NOBORI BIOLIMUS-ELUTING STENT AND XIENCE EVEROLIMUS-ELUTING STENT IN PATIENTS TREATED WITH IN-STENT RESTENOSIS

Researchers

Presenter

  • Takashi Hiromasa

Principal Investigators

  • Shoichi Kuramitsu

  • Takashi Morinaga

  • Yohei Kobayashi

  • Hiroyuki Jinnouchi

  • Takenori Domei

  • Makoto Hyodo

  • Shinichi Shirai

  • Kenji Ando

  • Masakiyo Nobuyoshi

Medical Centers

  • Kokura memorial hospital, Kitakyusyu, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Restenosis

  • Diabetes

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Crofelemer

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim